UCSF Alumni

Karin Gaensler, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, MSB, #770B
San Francisco CA 94143
Phone415-476-5259
vCardDownload vCard

Collapse Biography 
Collapse education and training
University of California, San FranciscoPost-Doc Fellow/Scholar1988 Medicine (Cancer Research Institute)
University of California, San Francisco Residency
Harvard UniversityM.D.1981School of Medicine

Collapse Overview 
Collapse overview
As a physician-scientist and member of the Hematological Malignancies and Stem Cell Transplantation Program and Helen Diller Family Cancer Center at UCSF, my clinical focus has been the treatment of hematological malignancies, combining chemotherapeutic and autologous or allogeneic bone marrow/ stem cell transplantation approaches. My laboratory has focused on the development of gene transfer and stem cell transplantation approaches for the treatment of hematologic disorders, with a current focus on the development of immunotherapeutic approaches to treat minimal residual disease (MRD) in older patients with acute myelogenous leukemia (AML). There is a major clinical unmet need for effective and safe therapies to increase progression-free and overall survival in older individuals with leukemia whose prognosis is grim.
Compelling evidence for the efficacy of immunotherapy in eliminating minimal residual disease (MRD) is provided by the superior outcomes of allogeneic hematopoietic stem cell transplants (HSCT) due to graft vs leukemia (GVL) effects. However, patients > 60 yo are often ineligible for allo-HSCT. Two vaccine approaches are being developed as part of a collaborative consortium at UCSF, UCLA, UC Davis, and King’s College, London.
Our vaccine project focuses on genetic engineering of autologous whole cell AML vaccines to express CD80, and IL-15, and IL-15 Receptor alpha (IL-15Rα). The leukemia-specific cytolytic activity stimulated by engineered, irradiated AML cell vaccines expressing IL-15/IL-15Ra/CD80 was tested in the murine 32Dp210 myeloid leukemia model that recapitulates many features of human AML. Proof of concept (POC) studies showed that treatment of leukemia-bearing hosts induced superior anti-leukemic immunity when compared with vaccines expressing either CD80, or IL15-IL15Rα alone and eradicated leukemia 80% in leukemic mice an effect mediated by CD8+ T cells. (Shi, Y. et al (2018)).
Based on these proof of concept studies we received a Catalyst award through the CTSI at UCSF, a Translational Research Program grant from the Leukemia and Lymphoma Society in 2017, and a CIRM Translational-1 grant in 2018 to pursue non-overlapping studies with cGMP reagents supporting submission of a Pre-IND package to the FDA. Most recently, we were awarded a CIRM CLIN 1 grant (12/2022)to pursue IND enabling studies. These studies are being pursued as part of a collaborative consortium with investigators at UCSF (M. Rosenblum, L. Damon, A. Nambiar, A.Combes and K. Ganapathi), UCLA (Donald Kohn), and King's College London (Farzin Farzaneh).
Show more

Collapse Research 
Collapse research activities and funding
Developing Engineered Autologous Leukemia vaccines to Target Residual Leukemic Stem Cells
CIRM TRAN-1 Feb 1, 2018 - Jan 31, 2023
Role: PI
Description: This award supports cGMP studies necessary for the submission of a Pre-IND application to the FDA. This involves scientific consortium of investigators at UCSF, UCLA, UC Davis, and King’s College London
Inducing effective anti-leukemic immunity with novel AML vaccines expressing IL15/IL-15Ra/CD80
Leukemia Lymphoma Society Oct 1, 2017 - Sep 30, 2022
Role: PI
Description: This project focuses on basic translational studies developing an engineered autologous AML vaccine Leukemia & Lymphoma Society of America
Efficacy and safety of novel CD80 IL15 IL15Ra expressing autologous AML vaccines
NIH R21CA177284Aug 6, 2013 - Jul 31, 2015
Role: Principal Investigator
Lentivirus-based positive/negative selection in minimally ablative transplants
NIH R01HL107974Dec 1, 2011 - Nov 30, 2015
Role: Principal Investigator
Neonatal Chemoselection Following Ex Vivo Gene Transfer For Hereditary Disorders
NIH R01HL082665May 12, 2008 - Apr 30, 2013
Role: Principal Investigator
Show more

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma. Leuk Lymphoma. 2025 May 07; 1-4. Othman T, Lo MM, Andreadis CB, Damon LE, Ferng TT, Gaensler KML, Lee JC, Martin TG, Olin RL, Sayre PH, Smith CC, Logan AC. PMID: 40329916.
    View in: PubMed   Mentions:    Fields:    
  2. Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults. J Geriatr Oncol. 2023 11; 14(8):101623. Huang LW, Shi Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Boscardin WJ, Steinman MA, Olin RL. PMID: 37678052; PMCID: PMC11101048.
    View in: PubMed   Mentions: 2     Fields:    Translation:Humans
  3. Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults. Transplant Cell Ther. 2022 06; 28(6):309.e1-309.e9. Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Huang CY, Olin RL. PMID: 35247612; PMCID: PMC9198006.
    View in: PubMed   Mentions: 2     Fields:    Translation:Humans
  4. Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis. Blood Cancer Discov. 2021 09; 2(5):434-449. Wang VE, Blaser BW, Patel RK, Behbehani GK, Rao AA, Durbin-Johnson B, Jiang T, Logan AC, Settles M, Mannis GN, Olin R, Damon LE, Martin TG, Sayre PH, Gaensler KM, McMahon E, Flanders M, Weinberg V, Ye CJ, Carbone DP, Munster PN, Fragiadakis GK, McCormick F, Andreadis C. PMID: 34514432; PMCID: PMC8425277.
    View in: PubMed   Mentions: 5     Fields:    Translation:Humans
  5. Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2020 01; 26(1):189-196. Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Steinman MA, Huang CY, Olin RL. PMID: 31493541; PMCID: PMC6942208.
    View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
  6. Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results. Clin Cancer Res. 2019 08 15; 25(16):4917-4923. Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C. PMID: 31152020.
    View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
  7. IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Blood Adv. 2018 11 27; 2(22):3177-3192. Shi Y, Dincheva-Vogel L, Ayemoba CE, Fung JP, Bergamaschi C, Pavlakis GN, Farzaneh F, Gaensler KML. PMID: 30482760; PMCID: PMC6258921.
    View in: PubMed   Mentions: 10     Fields:    
  8. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 01; 15(1):60-87. Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Horsfall R, Johnson RA, Juckett M, Klimek VM, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Shami PJ, Stein BL, Walker AR, Westervelt P, Zeidan A, Shead DA, Smith C. PMID: 28040720.
    View in: PubMed   Mentions: 117     Fields:    Translation:Humans
  9. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 06; 22(6):1030-1036. Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KML, Sayre PH, Wolf JL, Logan AC. PMID: 26899561.
    View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
  10. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission. Leuk Lymphoma. 2016 07; 57(7):1560-6. Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C. PMID: 26490487.
    View in: PubMed   Mentions: 1     Fields:    Translation:Humans
  11. Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis. PLoS One. 2016; 11(1):e0144561. Ikuta T, Sellak H, Odo N, Adekile AD, Gaensler KM. PMID: 26727002; PMCID: PMC4699757.
    View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
  12. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano Lett. 2015 Dec 09; 15(12):8099-107. Li B, Luo X, Deng B, Wang J, McComb DW, Shi Y, Gaensler KM, Tan X, Dunn AL, Kerlin BA, Dong Y. PMID: 26529392; PMCID: PMC4869688.
    View in: PubMed   Mentions: 106     Fields:    Translation:Humans
  13. The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice. Immun Ageing. 2015; 12:6. Tye GJ, Ioannou K, Amofah E, Quartey-Papafio R, Westrop SJ, Krishnamurthy P, Noble A, Harrison PM, Gaensler KML, Barber LD, Farzaneh F. PMID: 26157468; PMCID: PMC4495856.
    View in: PubMed   Mentions: 3  
  14. Myelodysplastic syndromes, version 2.2015. J Natl Compr Canc Netw. 2015 Mar; 13(3):261-72. Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Klimek V, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Scott B, Shami PJ, Stein BL, Westervelt P, Wheeler B, Shead DA, Smith C, National comprehensive cancer network. PMID: 25736003; PMCID: PMC4696005.
    View in: PubMed   Mentions: 23     Fields:    Translation:Humans
  15. A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):377-83. Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG. PMID: 25776193.
    View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
  16. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature. 2015 Jan 15; 517(7534):360-4. Barzel A, Paulk NK, Shi Y, Huang Y, Chu K, Zhang F, Valdmanis PN, Spector LP, Porteus MH, Gaensler KM, Kay MA. PMID: 25363772; PMCID: PMC4297598.
    View in: PubMed   Mentions: 142     Fields:    Translation:HumansAnimalsCells
  17. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4. Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, Venstrom JM, Wolf JL, Caballero L, Emi N, Martin TG. PMID: 25243620.
    View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
  18. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. J Geriatr Oncol. 2014 Jul; 5(3):238-44. Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL. PMID: 24894413.
    View in: PubMed   Mentions: 10     Fields:    Translation:Humans
  19. Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX. Gene Ther. 2013 Oct; 20(10):987-96. Shi Y, Falahati R, Zhang J, Flebbe-Rehwaldt L, Gaensler KM. PMID: 23759700; PMCID: PMC3795474.
    View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
  20. Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage. PLoS One. 2013; 8(5):e62351. Ito M, Ohba S, Gaensler K, Ronen SM, Mukherjee J, Pieper RO. PMID: 23667469; PMCID: PMC3646831.
    View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
  21. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression. Mol Ther. 2012 Nov; 20(11):2180-9. Falahati R, Zhang J, Flebbe-Rehwaldt L, Shi Y, Gerson SL, Gaensler KM. PMID: 22871662; PMCID: PMC3498795.
    View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
  22. MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood. Mol Ther Nucleic Acids. 2012 Aug 07; 1:e34. Mintz PJ, Sætrom P, Reebye V, Lundbæk MB, Lao K, Rossi JJ, Gaensler KM, Kasahara N, Nicholls JP, Jensen S, Haoudi A, Emara MM, Gordon MY, Habib NA. PMID: 23344176; PMCID: PMC3437805.
    View in: PubMed   Mentions: 7  
  23. Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding. J Biol Chem. 2011 Jul 15; 286(28):24819-27. Alhashem YN, Vinjamur DS, Basu M, Klingmüller U, Gaensler KM, Lloyd JA. PMID: 21610079; PMCID: PMC3137057.
    View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
  24. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation. Immunol Res. 2009; 44(1-3):112-26. Hacke K, Falahati R, Flebbe-Rehwaldt L, Kasahara N, Gaensler KM. PMID: 19048410; PMCID: PMC2938774.
    View in: PubMed   Mentions: 7     Fields:    
  25. Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma. Bone Marrow Transplant. 2008 Nov; 42(10):649-57. Damon L, Damon LE, Gaensler K, Kaplan L, Martin T, Rubenstein J, Linker C. PMID: 18679366; PMCID: PMC4372391.
    View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
  26. A mechanism for Ikaros regulation of human globin gene switching. Br J Haematol. 2008 May; 141(3):398-406. Keys JR, Tallack MR, Zhan Y, Papathanasiou P, Goodnow CC, Gaensler KM, Crossley M, Dekker J, Perkins AC. PMID: 18318763.
    View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
  27. Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. Proc Natl Acad Sci U S A. 2006 Apr 25; 103(17):6617-22. Rupon JW, Wang SZ, Gaensler K, Lloyd J, Ginder GD. PMID: 16608912; PMCID: PMC1458932.
    View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
  28. KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic beta-like globin genes in vivo. Blood. 2005 Oct 01; 106(7):2566-71. Basu P, Morris PE, Haar JL, Wani MA, Lingrel JB, Gaensler KM, Lloyd JA. PMID: 15947087; PMCID: PMC1895257.
    View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
  29. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther. 2003 Jul; 8(1):90-8. Lipshutz GS, Titre D, Brindle M, Bisconte AR, Contag CH, Gaensler KM. PMID: 12842432.
    View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
  30. Sequences in the (A)gamma-delta intergenic region are not required for stage-specific regulation of the human beta-globin gene locus. Proc Natl Acad Sci U S A. 2003 Mar 18; 100(6):3374-9. Gaensler KM, Zhang Z, Lin C, Yang S, Hardt K, Flebbe-Rehwaldt L. PMID: 12629213; PMCID: PMC152300.
    View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
  31. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther. 2001 Mar; 3(3):284-92. Lipshutz GS, Gruber CA, Hardy J, Contag CH, Gaensler KM. PMID: 11273769.
    View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
  32. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther. 2000 Oct; 2(4):374-80. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. PMID: 11020353.
    View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
  33. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature. 2000 Jul 06; 406(6791):82-6. May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M. PMID: 10894546.
    View in: PubMed   Mentions: 130     Fields:    Translation:HumansAnimalsCells
  34. Fetal gene transfer by transuterine injection of cationic liposome-DNA complexes. Nat Biotechnol. 1999 Dec; 17(12):1188-92. Gaensler KM, Tu G, Bruch S, Liggitt D, Lipshutz GS, Metkus A, Harrison M, Heath TD, Debs RJ. PMID: 10585716.
    View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
  35. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci U S A. 1999 Nov 09; 96(23):13324-9. Lipshutz GS, Sarkar R, Flebbe-Rehwaldt L, Kazazian H, Gaensler KM. PMID: 10557319; PMCID: PMC23946.
    View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
  36. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery. 1999 Aug; 126(2):171-7. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. PMID: 10455880.
    View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
  37. Adenovirus-mediated gene transfer in the midgestation fetal mouse. J Surg Res. 1999 Jun 15; 84(2):150-6. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KM. PMID: 10357912.
    View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
  38. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):14886-90. Chang JC, Lu R, Lin C, Xu SM, Kan YW, Porcu S, Carlson E, Kitamura M, Yang S, Flebbe-Rehwaldt L, Gaensler KM. PMID: 9843985; PMCID: PMC24545.
    View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
  39. The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice. Blood. 1997 Dec 01; 90(11):4602-9. Porcu S, Kitamura M, Witkowska E, Zhang Z, Mutero A, Lin C, Chang J, Gaensler KM. PMID: 9373272.
    View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
  40. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12267-71. Perkins AC, Gaensler KM, Orkin SH. PMID: 8901569; PMCID: PMC37979.
    View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
  41. Cationic liposome-mediated intravenous gene delivery. J Biol Chem. 1995 Oct 20; 270(42):24864-70. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K, Debs R. PMID: 7559609.
    View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
  42. Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human beta-globin locus in transgenic mice. Proc Natl Acad Sci U S A. 1993 Dec 01; 90(23):11381-5. Gaensler KM, Kitamura M, Kan YW. PMID: 8248258; PMCID: PMC47986.
    View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
  43. Aerosol gene delivery in vivo. Proc Natl Acad Sci U S A. 1992 Dec 01; 89(23):11277-81. Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R. PMID: 1454808; PMCID: PMC50533.
    View in: PubMed   Mentions: 38     Fields:    Translation:Animals
  44. Prolonged transgene expression in rodent lung cells. Am J Respir Cell Mol Biol. 1992 Oct; 7(4):406-13. Debs R, Pian M, Gaensler K, Clements J, Friend DS, Dobbs L. PMID: 1327013.
    View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
  45. Physical mapping of yeast artificial chromosomes containing sequences from the human beta-globin gene region. Genomics. 1991 Aug; 10(4):976-84. Gaensler KM, Burmeister M, Brownstein BH, Taillon-Miller P, Myers RM. PMID: 1916829.
    View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
  46. Genetic and biochemical analysis of the mouse beta-major globin promoter. Prog Clin Biol Res. 1989; 316A:117-27. Myers RM, Cowie A, Stuve L, Hartzog G, Gaensler K. PMID: 2594802.
    View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells